Compare IMPP & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMPP | MBOT |
|---|---|---|
| Founded | 1981 | 2010 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.7M | 134.3M |
| IPO Year | N/A | N/A |
| Metric | IMPP | MBOT |
|---|---|---|
| Price | $3.79 | $2.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $5.50 | ★ $8.75 |
| AVG Volume (30 Days) | 723.4K | ★ 1.5M |
| Earning Date | 02-12-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.03 | N/A |
| Revenue | ★ $136,071,654.00 | N/A |
| Revenue This Year | $7.55 | N/A |
| Revenue Next Year | $58.58 | $3,119.61 |
| P/E Ratio | $3.63 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.12 | $1.25 |
| 52 Week High | $6.57 | $4.67 |
| Indicator | IMPP | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 37.73 | 51.12 |
| Support Level | $3.63 | $2.05 |
| Resistance Level | $3.88 | $2.15 |
| Average True Range (ATR) | 0.16 | 0.10 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 56.86 | 75.02 |
Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.